Roxane gets first generic equivalent to Voltaren on June 23; ANDA/AADA June wrap-up.
Executive Summary
ROXANE GAINS FIRST GENERIC VOLTAREN ANDA APPROVAL on June 29 from FDA ("The Pink Sheet" July 3, T&G-13). The first off-patent version of Ciba-Geigy's nonsteroidal anti-inflammatory drug Voltaren will be available in 25 mg and 50 mg tablets.